EX-23.1 5 tv489357_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

Akari Therapeutics, Plc

London, United Kingdom

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-198109 and 333-207444) and the Registration Statements on Form F-3 (No. 333-220052) of Akari Therapeutics, Plc of our report dated July 18, 2018, relating to the consolidated financial statements, which appears in this Form 20-F.

/s/ BDO USA, LLP |
BDO USA, LLP |
New York, New York |
July 18, 2018 |